FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2019960723> ?p ?o ?g. }

• W2019960723 endingPage "387" @default.
• W2019960723 startingPage "379" @default.
• W2019960723 abstract "Rivaroxaban is an oral, direct factor Xa inhibitor. Routine coagulation monitoring is not required, but a quantitative determination of rivaroxaban concentrations might be useful in some clinical circumstances. This multicentre study assessed the suitability of the anti-factor Xa chromogenic assay for the measurement of rivaroxaban plasma concentrations (ng/ml) using rivaroxaban calibrators and controls, and the inter-laboratory precision of the measurement. Twenty-four centres in Europe and North America were provided with sets of rivaroxaban calibrators (0, 41, 209 and 422 ng/ml) and a set of rivaroxaban pooled human plasma controls (20, 199 and 662 ng/ml; the concentrations were unknown to the participating laboratories). The evaluation was carried out over 10 days by each laboratory using local anti-factor Xa reagents as well as the centrally provided reagent, a modified STA® Rotachrom® assay. A calibration curve was produced each day, and the day-to-day precision was evaluated by testing three human plasma controls. When using the local anti-factor Xa reagents, the mean rivaroxaban concentrations (measured/actual values) were: 17/20, 205/199 and 668/662 ng/ml, and the coefficient of variance (CV) was 37.0%, 13.7% and 14.1%, respectively. When the modified STA Rotachrom method was used, the measured/actual values were: 18/20, 199/199 and 656/662 ng/ml, and the CV was 19.1%, 10.9% and 10.0%, respectively. The results suggest that, by using rivaroxaban calibrators and controls, the anti-factor Xa chromogenic method is suitable for measuring a wide range of rivaroxaban plasma concentrations (20-660 ng/ml), which covers the expected rivaroxaban plasma levels after therapeutic doses." @default.
• W2019960723 created "2016-06-24" @default.
• W2019960723 creator A5000669194 @default.
• W2019960723 creator A5023161395 @default.
• W2019960723 creator A5030800401 @default.
• W2019960723 creator A5046190545 @default.
• W2019960723 creator A5054799604 @default.
• W2019960723 creator A5062695817 @default.
• W2019960723 creator A5067806063 @default.
• W2019960723 creator A5070686719 @default.
• W2019960723 creator A5084062066 @default.
• W2019960723 date "2012-01-01" @default.
• W2019960723 modified "2023-09-26" @default.
• W2019960723 title "Evaluation of the anti-factor Xa chromogenic assay for the measurement of rivaroxaban plasma concentrations using calibrators and controls" @default.
• W2019960723 cites W1483138648 @default.
• W2019960723 cites W1969218311 @default.
• W2019960723 cites W1981633543 @default.
• W2019960723 cites W1984106364 @default.
• W2019960723 cites W1989930316 @default.
• W2019960723 cites W2014491911 @default.
• W2019960723 cites W2015940002 @default.
• W2019960723 cites W2025711779 @default.
• W2019960723 cites W2028162842 @default.
• W2019960723 cites W2036007875 @default.
• W2019960723 cites W2036506340 @default.
• W2019960723 cites W2041254215 @default.
• W2019960723 cites W2045987573 @default.
• W2019960723 cites W2048928876 @default.
• W2019960723 cites W2049593282 @default.
• W2019960723 cites W2051126553 @default.
• W2019960723 cites W2058280673 @default.
• W2019960723 cites W2060578439 @default.
• W2019960723 cites W2064826963 @default.
• W2019960723 cites W2068476516 @default.
• W2019960723 cites W2075341962 @default.
• W2019960723 cites W2087630384 @default.
• W2019960723 cites W2097854437 @default.
• W2019960723 cites W2103196751 @default.
• W2019960723 cites W2103247642 @default.
• W2019960723 cites W2115787552 @default.
• W2019960723 cites W2123448465 @default.
• W2019960723 cites W2150567120 @default.
• W2019960723 cites W2151252098 @default.
• W2019960723 cites W2157224841 @default.
• W2019960723 cites W2561317409 @default.
• W2019960723 cites W2979679544 @default.
• W2019960723 cites W4229553011 @default.
• W2019960723 doi "https://doi.org/10.1160/th11-06-0391" @default.
• W2019960723 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22187012" @default.
• W2019960723 hasPublicationYear "2012" @default.
• W2019960723 type Work @default.
• W2019960723 sameAs 2019960723 @default.
• W2019960723 citedByCount "216" @default.
• W2019960723 countsByYear W20199607232012 @default.
• W2019960723 countsByYear W20199607232013 @default.
• W2019960723 countsByYear W20199607232014 @default.
• W2019960723 countsByYear W20199607232015 @default.
• W2019960723 countsByYear W20199607232016 @default.
• W2019960723 countsByYear W20199607232017 @default.
• W2019960723 countsByYear W20199607232018 @default.
• W2019960723 countsByYear W20199607232019 @default.
• W2019960723 countsByYear W20199607232020 @default.
• W2019960723 countsByYear W20199607232021 @default.
• W2019960723 countsByYear W20199607232022 @default.
• W2019960723 countsByYear W20199607232023 @default.
• W2019960723 crossrefType "journal-article" @default.
• W2019960723 hasAuthorship W2019960723A5000669194 @default.
• W2019960723 hasAuthorship W2019960723A5023161395 @default.
• W2019960723 hasAuthorship W2019960723A5030800401 @default.
• W2019960723 hasAuthorship W2019960723A5046190545 @default.
• W2019960723 hasAuthorship W2019960723A5054799604 @default.
• W2019960723 hasAuthorship W2019960723A5062695817 @default.
• W2019960723 hasAuthorship W2019960723A5067806063 @default.
• W2019960723 hasAuthorship W2019960723A5070686719 @default.
• W2019960723 hasAuthorship W2019960723A5084062066 @default.
• W2019960723 hasConcept C126322002 @default.
• W2019960723 hasConcept C128463046 @default.
• W2019960723 hasConcept C185592680 @default.
• W2019960723 hasConcept C2776301958 @default.
• W2019960723 hasConcept C2778661090 @default.
• W2019960723 hasConcept C2779161974 @default.
• W2019960723 hasConcept C43617362 @default.
• W2019960723 hasConcept C71924100 @default.
• W2019960723 hasConceptScore W2019960723C126322002 @default.
• W2019960723 hasConceptScore W2019960723C128463046 @default.
• W2019960723 hasConceptScore W2019960723C185592680 @default.
• W2019960723 hasConceptScore W2019960723C2776301958 @default.
• W2019960723 hasConceptScore W2019960723C2778661090 @default.
• W2019960723 hasConceptScore W2019960723C2779161974 @default.
• W2019960723 hasConceptScore W2019960723C43617362 @default.
• W2019960723 hasConceptScore W2019960723C71924100 @default.
• W2019960723 hasIssue "02" @default.
• W2019960723 hasLocation W20199607231 @default.
• W2019960723 hasLocation W20199607232 @default.
• W2019960723 hasOpenAccess W2019960723 @default.
• W2019960723 hasPrimaryLocation W20199607231 @default.
• W2019960723 hasRelatedWork W1484066528 @default.
• W2019960723 hasRelatedWork W1993884933 @default.

• next